Abstract
A 13-year-old girl with acute lymphoblastic leukemia (ALL) developed extremely high plasma triglyceride (TG) concentrations of 103 mmol/l (reference value <1.8 mmol/l) during combination treatment with corticosteroids and asparaginase. corticosteroids are known to induce the production of tg-rich particles. on the other hand, corticosteroids increase the activity of lipoprotein lipase (lpl), a key enzyme in the removal of tg from plasma. generally, the increased lpl activity prevents an extreme rise in tg levels upon therapy with corticosteroids. in our patient, we found that the corticosteroid-induced lpl activity dramatically declined after therapy with l-asparaginase. this suggests that the extensive hypertriglyceridemia in our patient was due to an l-asparaginase-induced decrease in lpl activity. this hypothesis was further supported by the finding that hypertriglyceridemia was less severe when corticosteroids and asparaginase were given separately.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hoogerbrugge, N., Jansen, H. & Hoogerbrugge, P. Transient hyperlipidemia during treatment of ALL with L-asparaginase is related to decreased lipoprotein lipase activity. Leukemia 11, 1377–1379 (1997). https://doi.org/10.1038/sj.leu.2400703
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2400703
Keywords
This article is cited by
-
Incidence and Management of Thromboembolism in Patients with Acute Leukemia
Indian Journal of Hematology and Blood Transfusion (2023)
-
Symptomatic severe hypertriglyceridaemia with asparaginase therapy in acute lymphoblastic leukaemia (ALL) and lymphoblastic lymphoma: is rechallenging safe?
International Journal of Hematology (2011)